Scarica l'app Stockscreener
4.30
2.04%
-0.12
Precedente Chiudi:
$4.42
Aprire:
$4.45
Volume 24 ore:
67,966
Relative Volume:
0.42
Capitalizzazione di mercato:
$46.44M
Reddito:
-
Utile/perdita netta:
$-19.25M
Rapporto P/E:
-2.4157
EPS:
-1.78
Flusso di cassa netto:
$-17.87M
1 W Prestazione:
-6.28%
1M Prestazione:
+5.61%
6M Prestazione:
+24.07%
1 anno Prestazione:
+23.71%
Intervallo 1D:
$4.25
$4.58
Intervallo di 1 settimana:
$4.0705
$4.68
Portata 52W:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Nome
Lantern Pharma Inc
Settore
Industria
Telefono
972-277-1136
Indirizzo
1920 MCKINNEY AVENUE, DALLAS, TX
Confronta LTRN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.30 | 47.19M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.00 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
484.91 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.87 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.99 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.64 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-07 | Iniziato | H.C. Wainwright | Buy |
Lantern Pharma Inc Borsa (LTRN) Ultime notizie
RADR(R) Platform Powers Lantern Pharma's (NASDAQ: LTRN) Push Into Rare Pediatric Brain Cancer Treatment - Digital Journal
Technical analysis overview for Lantern Pharma Inc. stockDollar Strength & Consistent Return Investment Signals - newser.com
When is the best time to exit Lantern Pharma Inc.Trade Risk Assessment & High Win Rate Trade Alerts - newser.com
Has Lantern Pharma Inc. formed a bullish divergencePortfolio Update Report & Safe Capital Investment Plans - newser.com
Why Lantern Pharma Inc. stock is favored by pension fundsEarnings Overview Summary & Safe Entry Point Identification - newser.com
Is Lantern Pharma Inc. stock a buy before product launches2025 Analyst Calls & Reliable Trade Execution Plans - newser.com
How to build a custom watchlist for Lantern Pharma Inc.Weekly Trade Summary & Safe Entry Momentum Tips - newser.com
Lantern Pharma Advances Pediatric Brain Cancer Treatment Using AI Platform - citybuzz
Lantern Pharma Preps 2026 Trial for Rare Pediatric Brain Cancer After FDA Guidance - Dallas Innovates
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Amarillo Globe-News
Trend analysis for Lantern Pharma Inc. this week2025 Market Overview & Daily Price Action Insights - newser.com
Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma and New Board Member Dr. Lee Schalop Discuss How AI Can Reshape CNS Oncology Drug Development - Digital Journal
Using economic indicators to assess Lantern Pharma Inc. potentialWeekly Stock Summary & Weekly High Potential Alerts - newser.com
Will Lantern Pharma Inc. stock recover after recent drop2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Lantern Pharma (NASDAQ:LTRN) Trading Down 6.1% – Here’s What Happened - Defense World
Lantern Pharma (NASDAQ:LTRN) Rating Increased to Hold at Wall Street Zen - Defense World
Can momentum traders help lift Lantern Pharma Inc.Market Sentiment Review & Comprehensive Market Scan Reports - newser.com
Visual analytics tools that track Lantern Pharma Inc. performanceJuly 2025 Snapshot & Capital Efficient Trading Techniques - newser.com
Why Lantern Pharma Inc. is moving todayMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lantern Pharma Inc Azioni (LTRN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
3.93%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):